DSG2 and breast cancer: Chang et al.65 reported a significantly (P=0.008) lower distant metastasis-free survival rate in breast cancer patients with high expression of DSG2, indicating that DSG2 plays a key role in breast cancer metastasis and can be considered a prognostic marker.